yesterday close provid busi updat relat
outbreak first packag food compani provid updat
follow outbreak becom global natur first calendar year report
compani address impact organ sale growth much
investor alreadi see scanner data also updat expect
flow profit specif look organ sale gain
yoy vs consensu roughli yoy previous sort
growth increasingli expect light recent data
interestingli regard profit state expect full benefit
increment sale quarter flow net incom adjust ebitda
ep due ad expens incur meet acceler growth addit
headwind previous disclos februari earn call belief
increment sale growth industri could well lead outsiz
profit closer given increas volum leverag also higher
variabl contribut margin industri particip look reduc assort
tail sku focu key packag size maxim product output limit costli
equip changeov pull back promot spend store labor
focu keep shelv stock versu chang price tag shelf sure wed
expect increment cost mani packag food compani alreadi announc
enhanc employe benefit includ temporari premium payment
like aspect run util ideal note
notabl mention full fiscal year expect posit
outweigh cost though alreadi said wed remind investor
deal suppli chain issu long came
though believ plant remain oper time look
increment improv vs previou forecast ebitda
roughli line increment chang organ sale estim
quarterli annual ep usd
consensu number bloomberg receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
lower usd
return equiti ttm
idc link barclay live interact chart
equal weight top-lin acceler
anticip admittedli come
believ combin inflat net cost
save reinvest need limit visibl
potenti earn ramp futur year along
need de-lev keep us neutral share
abl drive continu revenu growth
achiev increment cost effici see upsid
ebitda multipl
get upsid case
face difficult top-lin challeng
anticip addit invest need
see downsid ebitda
multipl translat downsid case
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
specif look yoy organ sale gain ebitda
declin yoy vs yoy yoy previous
forecast organ sale gain yoy vs yoy previous ebitda
yoy declin vs yoy previous target price vs
previous predic multipl revis ebitda estim
repres discount peer previous price target
predic ev/ebitda multipl ebitda forecast
andrew lazar herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
procedur pleas
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
unless otherwis indic price sourc bloomberg reflect close price relev trade market may
last avail price time public
barclay bank plc and/or affili lead manag co-lead manag publicli disclos offer secur issuer
 employe non-execut director barclay plc director issuer
cd barclay bank plc and/or affili market-mak debt secur issu issuer
ce barclay bank plc and/or affili market-mak equiti secur issu issuer
barclay bank plc and/or affili receiv compens invest bank servic issuer past month
 barclay bank plc and/or affili expect receiv intend seek compens invest bank servic issuer
within next month
fa barclay bank plc and/or affili benefici own class equiti secur issuer calcul accord
us regul
fb barclay bank plc and/or affili benefici own long posit class equiti secur issuer
calcul accord eu regul
fc barclay bank plc and/or affili benefici own short posit class equiti secur issuer
calcul accord eu regul
fd barclay bank plc and/or affili benefici own class equiti secur issuer calcul accord
south korean regul
gd one research analyst fundament credit coverag team member household long posit
common equiti secur issuer
ge one research analyst fundament equiti coverag team member household long posit
common equiti secur issuer
 issuer benefici own class common equiti secur barclay plc
barclay bank plc and/or affili parti agreement issuer provis financi servic barclay bank plc and/or
affili
 barclay bank plc and/or affili liquid provid and/or trade regularli secur issuer and/or relat
